Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Relationship between plasma plasminogen activator inhibitor 1 and insulin resistance.

Diabetes/metabolism research and reviews - 1 Jan 2000

Bastard J P, Piéroni L, Hainque B

Abstract excerpt

High plasminogen activator inhibitor 1 (PAI-1) levels are associated with an increased cardiovascular risk of atherothrombosis. Furthermore, increased plasma PAI-1 levels are associated with dyslipidemia, hyperinsulinemia and hypertension. This association between PAI-1 and metabolic components of the Metabolic Syndrome could explain the predisposition of insulin resistant patients to atherothrombosis. Recent...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Adipose Tissue
Share to Arteriosclerosis
Share to Blood Glucose

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Diabetes Mellitus

Share to Fatty Liver

Share to gamma-Glutamyltransferase

Share to Hyperlipidemias

Share to Plasminogen Activator Inhibitor 1

Source

Identifiers

PMID: 10867719
DOI: 10.1002/1520-7560(200005/06)16:3<192::aid-dmrr114>3.0.co;2-g

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Relationship between plasma plasminogen activator inhibitor 1 and insulin resistance.PMID 10867719Read ↗

Plasma plasminogen activator inhibitor 1, insulin resistance and android obesity.Semantic proximity Read ↗

PAI-1, obesity, insulin resistance and risk of cardiovascular events.Semantic proximity Read ↗

The relationships between insulin and plasminogen activator inhibitor 1 levels: assessment in groups of subjects with dyslipidaemia and hypertension.Semantic proximity Read ↗

Relation of components of insulin resistance syndrome to coronary disease risk.Semantic proximity Read ↗

Determinants of plasminogen activator inhibitor 1 activity in treated NIDDM and its relation to a polymorphism in the plasminogen activator inhibitor 1 gene.Semantic proximity Read ↗

Body adiposity but not insulin resistance is associated with -675 4G/5G polymorphism in the PAI-1 gene in a sample of Mexican children.Semantic proximity Read ↗

Insulin Resistance and Its Potential Role in Pregnancy-Induced HypertensionSemantic proximity Read ↗

Elevated plasma activator inhibitor 1 is not related to insulin resistance and to gene polymorphism in healthy centenarians.Semantic proximity Read ↗

Targeted expression of plasminogen activator inhibitor(PAI)-1 to the stomach inhibits gut-brain signalling by the satiety hormone cholecystokinin (CCK)Semantic proximity Read ↗

PAI-1 concentrations in first-degree relatives of patients with non-insulin-dependent diabetes: metabolic and genetic associations.Semantic proximity Read ↗

Effect of plasminogen activator inhibitor-1 deficiency on nutritionally-induced obesity in mice.Semantic proximity Read ↗

Promoter (4G/5G) plasminogen activator inhibitor-1 genotype and plasminogen activator inhibitor-1 levels in blacks, Hispanics, and non-Hispanic whites: the Insulin Resistance Atherosclerosis Study.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.